Test Discontinuations Memorandum – Mitochondrial

Effective August 16, 2016, in a continuing effort to optimize our offerings, these changes will be made.

The following will be discontinued. Single gene components of each panel may also be affected.

  • Tier 1 Severe Combined Immunodeficiency (SCID) Panel (TC 20300)
  • Omenn Syndrome Panel (TC 20500)
  • Congenital Myopathy Panel (TC 20700)
  • Congenital Muscular Dystrophy Panel (TC 20900)
  • SCID Comprehensive Panel (TC 21500)
  • Congenital Myasthenic Syndrome Panel (TC 24100)
  • Muscular Dystrophy Panel (TC 24400)
  • Congenital & Distal Myopathy Panel (TC 24500)
Previous Post
Test Updates Memorandum – Mitochondrial
Next Post
Test Discontinuation Memorandum
Menu